Harvard Bioscience (HBIO) Tops Q4 EPS by 1c
Tweet
Share
E-mailGet Alerts HBIO Hot Sheet
Price: $8.11 --0%
EPS Growth %: -800.0%
Financial Fact:
Cost of product revenues: 13.32M
Today's EPS Names:
PMCB, PLCE, DOMO, More
EPS Growth %: -800.0%
Financial Fact:
Cost of product revenues: 13.32M
Today's EPS Names:
PMCB, PLCE, DOMO, More
Join SI Premium – FREE
Harvard Bioscience (NASDAQ: HBIO) reported Q4 EPS of $0.06, $0.01 better than the analyst estimate of $0.05. Revenue for the quarter came in at $24.6 million versus the consensus estimate of $24.15 million.
GUIDANCE:
Harvard Bioscience sees Q1 2025 revenue of $19-21 million.
For earnings history and earnings-related data on Harvard Bioscience (HBIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SailPoint Technologies Holdings (SAIL) PT Raised to $25 by Cantor Fitzgerald on Solid Checks
- Palo Alto Networks (PANW) PT Raised to $430 at Scotiabank
- Bitzero repays $25M debt, advances Nordic data center sites
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
